AXSM logo

Axsome Therapeutics, Inc. (AXSM) Cash from investing

annual CFI:

-$270.00K+$312.00K(+53.61%)
December 31, 2024

Summary

  • As of today (August 22, 2025), AXSM annual cash flow from investing activities is -$270.00 thousand, with the most recent change of +$312.00 thousand (+53.61%) on December 31, 2024.
  • During the last 3 years, AXSM annual CFI has risen by +$37.50 thousand (+12.20%).

Performance

AXSM Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAXSMcash flow metrics

quarterly CFI:

-$13.00K+$325.00K(+96.15%)
June 30, 2025

Summary

  • As of today (August 22, 2025), AXSM quarterly cash flow from investing activities is -$13.00 thousand, with the most recent change of +$325.00 thousand (+96.15%) on June 30, 2025.
  • Over the past year, AXSM quarterly CFI has increased by +$39.00 thousand (+75.00%).

Performance

AXSM quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAXSMcash flow metrics

TTM CFI:

-$471.00K+$39.00K(+7.65%)
June 30, 2025

Summary

  • As of today (August 22, 2025), AXSM TTM cash flow from investing activities is -$471.00 thousand, with the most recent change of +$39.00 thousand (+7.65%) on June 30, 2025.
  • Over the past year, AXSM TTM CFI has increased by +$57.00 thousand (+10.80%).
  • AXSM TTM CFI is now -4657.58% below its all-time high of -$9900.00, reached on December 31, 2017.

Performance

AXSM TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAXSMcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AXSM Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+53.6%+75.0%+10.8%
3 y3 years+12.2%+100.0%+99.1%
5 y5 years-1577.0%-828.6%-2958.4%

AXSM Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+99.5%-85.7%+100.0%-90.7%+99.1%
5 y5-year-1577.0%+99.5%<-9999.0%+100.0%-2958.4%+99.1%
alltimeall time<-9999.0%+99.5%<-9999.0%+100.0%-4657.6%+99.1%

AXSM Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$13.00K(-96.2%)
-$471.00K(-7.6%)
Mar 2025
-
-$338.00K(+1026.7%)
-$510.00K(+88.9%)
Dec 2024
-$270.00K(-53.6%)
-$30.00K(-66.7%)
-$270.00K(+9.3%)
Sep 2024
-
-$90.00K(+73.1%)
-$247.00K(-53.2%)
Jun 2024
-
-$52.00K(-46.9%)
-$528.00K(-13.3%)
Mar 2024
-
-$98.00K(+1300.0%)
-$609.00K(+4.6%)
Dec 2023
-$582.00K(-98.9%)
-$7000.00(-98.1%)
-$582.00K(-23.0%)
Sep 2023
-
-$371.00K(+178.9%)
-$755.90K(+67.6%)
Jun 2023
-
-$133.00K(+87.3%)
-$451.00K(-99.2%)
Mar 2023
-
-$71.00K(-60.8%)
-$53.56M(-0.3%)
Dec 2022
-$53.70M(>+9900.0%)
-$180.90K(+173.7%)
-$53.70M(+0.3%)
Sep 2022
-
-$66.10K(-99.9%)
-$53.52M(-0.4%)
Jun 2022
-
-$53.24M(>+9900.0%)
-$53.71M(>+9900.0%)
Mar 2022
-
-$213.70K(<-9900.0%)
-$491.30K(+59.7%)
Dec 2021
-$307.50K(+569.9%)
$0.00(-100.0%)
-$307.60K(-6.2%)
Sep 2021
-
-$258.70K(+1268.8%)
-$327.90K(+290.4%)
Jun 2021
-
-$18.90K(-37.0%)
-$84.00K(+26.3%)
Mar 2021
-
-$30.00K(+47.8%)
-$66.50K(+45.2%)
Dec 2020
-$45.90K(+185.1%)
-$20.30K(+37.2%)
-$45.80K(+69.6%)
Sep 2020
-
-$14.80K(+957.1%)
-$27.00K(+75.3%)
Jun 2020
-
-$1400.00(-84.9%)
-$15.40K(-39.6%)
Mar 2020
-
-$9300.00(+520.0%)
-$25.50K(+57.4%)
DateAnnualQuarterlyTTM
Dec 2019
-$16.10K(-50.8%)
-$1500.00(-53.1%)
-$16.20K(+10.2%)
Sep 2019
-
-$3200.00(-72.2%)
-$14.70K(-26.5%)
Jun 2019
-
-$11.50K(<-9900.0%)
-$20.00K(+10.5%)
Mar 2019
-
$0.00(0.0%)
-$18.10K(-44.6%)
Dec 2018
-$32.70K(+230.3%)
$0.00(-100.0%)
-$32.70K(0.0%)
Sep 2018
-
-$8500.00(-11.5%)
-$32.70K(+17.6%)
Jun 2018
-
-$9600.00(-34.2%)
-$27.80K(+28.7%)
Mar 2018
-
-$14.60K(<-9900.0%)
-$21.60K(+118.2%)
Dec 2017
-$9900.00(-90.5%)
$0.00(-100.0%)
-$9900.00(-38.1%)
Sep 2017
-
-$3600.00(+5.9%)
-$16.00K(-82.0%)
Jun 2017
-
-$3400.00(+17.2%)
-$88.70K(-8.5%)
Mar 2017
-
-$2900.00(-52.5%)
-$96.90K(-7.4%)
Dec 2016
-$104.60K(+417.8%)
-$6100.00(-92.0%)
-$104.70K(+1.9%)
Sep 2016
-
-$76.30K(+557.8%)
-$102.70K(+233.4%)
Jun 2016
-
-$11.60K(+8.4%)
-$30.80K(+49.5%)
Mar 2016
-
-$10.70K(+161.0%)
-$20.60K(+2.0%)
Dec 2015
-$20.20K(<-9900.0%)
-$4100.00(-6.8%)
-$20.20K(+25.5%)
Sep 2015
-
-$4400.00(+214.3%)
-$16.10K(+37.6%)
Jun 2015
-
-$1400.00(-86.4%)
-$11.70K(+13.6%)
Mar 2015
-
-$10.30K
-$10.30K
Dec 2014
$0.00(0.0%)
-
-
Dec 2013
$0.00
-
-

FAQ

  • What is Axsome Therapeutics, Inc. annual cash flow from investing activities?
  • What is the all time high annual CFI for Axsome Therapeutics, Inc.?
  • What is Axsome Therapeutics, Inc. annual CFI year-on-year change?
  • What is Axsome Therapeutics, Inc. quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Axsome Therapeutics, Inc.?
  • What is Axsome Therapeutics, Inc. quarterly CFI year-on-year change?
  • What is Axsome Therapeutics, Inc. TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Axsome Therapeutics, Inc.?
  • What is Axsome Therapeutics, Inc. TTM CFI year-on-year change?

What is Axsome Therapeutics, Inc. annual cash flow from investing activities?

The current annual CFI of AXSM is -$270.00K

What is the all time high annual CFI for Axsome Therapeutics, Inc.?

Axsome Therapeutics, Inc. all-time high annual cash flow from investing activities is $0.00

What is Axsome Therapeutics, Inc. annual CFI year-on-year change?

Over the past year, AXSM annual cash flow from investing activities has changed by +$312.00K (+53.61%)

What is Axsome Therapeutics, Inc. quarterly cash flow from investing activities?

The current quarterly CFI of AXSM is -$13.00K

What is the all time high quarterly CFI for Axsome Therapeutics, Inc.?

Axsome Therapeutics, Inc. all-time high quarterly cash flow from investing activities is $0.00

What is Axsome Therapeutics, Inc. quarterly CFI year-on-year change?

Over the past year, AXSM quarterly cash flow from investing activities has changed by +$39.00K (+75.00%)

What is Axsome Therapeutics, Inc. TTM cash flow from investing activities?

The current TTM CFI of AXSM is -$471.00K

What is the all time high TTM CFI for Axsome Therapeutics, Inc.?

Axsome Therapeutics, Inc. all-time high TTM cash flow from investing activities is -$9900.00

What is Axsome Therapeutics, Inc. TTM CFI year-on-year change?

Over the past year, AXSM TTM cash flow from investing activities has changed by +$57.00K (+10.80%)
On this page